drugset / Trial / NCT02973581

SPI-directed Analgesia for Vitreoretinal Surgeries

NCT02973581

RandomizedParallel-groupSingle-blindDiagnostic

Summary

The aim of this randomized trial is to assess the efficacy of SPI-directed analgesia for vitreoretinal surgeries (VRS), presence of PONV and oculocardiac reflex (OCR) and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients received general anaesthesia alone or combined with either preemptive analgesia using topical solution of 0,5% proxymetacaine or peribulbar block (0,5% bupivacaine with 2% lidokaine) or preemptive intravenous infusion of 1,0 g of metamizol or preemptive intravenous infusion of acetaminophen in a doseof 10-15mg/kg of body weight.

Timeline

Start
2016-02
Primary completion
2017-02
Completion
2017-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 10 mg/kg Intravenous
Subject Acetaminophen Small molecule 15 mg/kg Intravenous
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 2.5 ml Other
Subject Lidocaine Other / unclassified 2 % Other
Subject Lidocaine Other / unclassified 2.5 ml Other
Subject Proparacaine Other / unclassified 0.5 % Topical
Subject dipyrone Unknown 1 g Intravenous
Subject dipyrone Unknown 1.25 g Intravenous

Indications

No indication recorded.